Back to ARNA Stock Lookup

ARNA – Upgrades

Jun 28, 2012 03:39 PM UPDATE: JPMorgan Upgrades Orexigen Therapeutics (OREX) to Overweight, Best Opportunity in Obesity Space
May 11, 2012 11:23 AM Piper Jaffray Upgrades Arena Pharma (ARNA) to Overweight
May 11, 2012 08:36 AM Leerink Swann Upgrades Arena Pharma (ARNA) to Outperform; Positive Panel Vote For Lorcaserin
May 11, 2012 07:54 AM Jefferies Upgrades Arena Pharma (ARNA) to Buy
May 9, 2012 07:25 AM BMO Capital Upgrades Arena Pharma (ARNA) to Outperform, Raises Target 600%
Nov 28, 2011 07:24 AM Piper Jaffray Upgrades Arena Pharma (ARNA) to Overweight
Dec 23, 2010 10:26 AM Summer Street Upgrades Arena Pharma (ARNA) to Neutral; Some Clarity From This Week’s FDA Meeting
Jul 16, 2010 09:01 AM Arena Pharmaceuticals (ARNA): Upgraded to Overweight at J.P. Morgan
Jul 16, 2010 08:10 AM J.P. Morgan on Biotechnology and Drugs Stocks; Upgrades ARNA, Cuts VVUS
Jul 2, 2010 07:05 AM Leerink Swann Upgrades Arena Pharmaceuticals (ARNA) to Outperform; Lorcaserin U.S. Partnership Announced
Feb 4, 2010 07:39 AM Rodman & Renshaw Upgrades Arena Pharmaceutical (ARNA) to Market Perform
May 20, 2009 01:12 PM Barclays Gets Bullish On US Biotechnology Sector (BBH)
Jan 15, 2008 07:46 AM BofA Upgrades Arena Pharmaceuticals (ARNA) to Buy
Dec 22, 2006 08:25 AM AG Edwards upgrades Arena Pharma (ARNA) to Buy
Sep 6, 2005 07:38 AM CIBC upgrades ARNA to Outperform

Back to ARNA Stock Lookup